Skip Nav Destination
Issues
Commentary
Research Articles
Metabolic Gene Polymorphism Frequencies in Control Populations1
Seymour Garte; Laura Gaspari; Anna-Karin Alexandrie; Christine Ambrosone; Herman Autrup; Judith L. Autrup; Helena Baranova; Lise Bathum; Simone Benhamou; Paolo Boffetta; Christine Bouchardy; Katja Breskvar; Jurgen Brockmoller; Ingolf Cascorbi; Margie L. Clapper; Christiane Coutelle; Ann Daly; Marco Dell’Omo; Vita Dolzan; Carolyn M. Dresler; Anthony Fryer; Aage Haugen; David W. Hein; Allan Hildesheim; Ari Hirvonen; Ling-Ling Hsieh; Magnus Ingelman-Sundberg; Ivan Kalina; Daehee Kang; Masahiro Kihara; Chikako Kiyohara; Pierre Kremers; Philip Lazarus; Loïc Le Marchand; Maria Celeste Lechner; Ester M. M. van Lieshout; Stephanie London; Johannes J. Manni; Christine M. Maugard; Shunji Morita; Valle Nazar-Stewart; Kazumasa Noda; Yoshio Oda; Fritz F. Parl; Roberta Pastorelli; Irene Persson; Wilbert H. M. Peters; Agneta Rannug; Timothy Rebbeck; Angela Risch; Liliane Roelandt; Marjorie Romkes; David Ryberg; Jan Salagovic; Bernadette Schoket; Janeric Seidegard; Peter G. Shields; Edith Sim; Daniel Sinnet; Richard C. Strange; Isabel Stücker; Haruhiko Sugimura; Jordi To-Figueras; Paolo Vineis; Mimi C. Yu; Emanuela Taioli
Combined Effects of Well-done Red Meat, Smoking, and Rapid N-Acetyltransferase 2 and CYP1A2 Phenotypes in Increasing Colorectal Cancer Risk1
Loïc Le Marchand; Jean H. Hankin; Lynne R. Wilkens; Lisa M. Pierce; Adrian Franke; Laurence N. Kolonel; Ann Seifried; Laurie J. Custer; Wendy Chang; Annette Lum-Jones; Timothy Donlon
Association of Methylenetetrahydrofolate Reductase Polymorphism C677T and Dietary Folate with the Risk of Cervical Dysplasia1
Marc T. Goodman; Katharine McDuffie; Brenda Hernandez; Lynne R. Wilkens; Cathy C. Bertram; Jeffrey Killeen; Loïc Le Marchand; Jacob Selhub; Suzanne Murphy; Timothy A. Donlon
The Steroid 5α-Reductase Type II TA Repeat Polymorphism Is Not Associated with Risk of Breast or Ovarian Cancer in Australian Women1
Amanda B. Spurdle; John L. Hopper; Xiaoqing Chen; Gillian S. Dite; Margaret R. E. McCredie; Graham G. Giles; Deon J. Venter; Melissa C. Southey; David M. Purdie; Georgia Chenevix-Trench
Short Communications
Null Results in Brief
Letters to the Editor
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.